title: Otomycosis: clinical and mycological study of 97 cases.
abstract: OBJECTIVE
  To report otomycosis in a retrospective study and correlate clinical, epidemiological and therapeutic factors.
  
  
  METHODS
  This study comprises 97 cases of clinically and mycologically proven otomycosis or fungal otitis externa gathered during a 12-year period.
  
  
  RESULTS
  Most cases were unilateral (90.7%) and the main predisposing factors associated with the disease were trauma (secondary to the constant scratching) and the use of topical antibiotics. Major causal agents were several species of Aspergillus (63.9%), of which Aspergillus flavus was commonest (26%), followed by Candida albicans (26.8%) and Aspergillus niger (21%).
  
  
  CONCLUSIONS
  The treatment of choice is mainly local toilet of the external auditory canal and the use of systemic antifungal agents to prevent re-infection and the spread of disease.
authors.affiliation: Hospital General de México OD, Mycology Department, Dermatology Service, Dr. Balmis 148, Col Doctores, CP 06720, México DF.
authors.forename: J
authors.initials: J
authors.lastname: Araiza
authors.forename: P
authors.initials: P
authors.lastname: Canseco
authors.forename: A
authors.initials: A
authors.lastname: Bonifaz
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications*; D001231:Aspergillus flavus / Q000302:isolation & purification; D001234:Aspergillus niger / Q000302:isolation & purification; D002648:Child; D004427:Ear Diseases / Q000188:drug therapy* / Q000382:microbiology*; D005260:Female; D006801:Humans; D008297:Male; D008622:Merbromin / Q000627:therapeutic use; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology*; D009761:Nystatin / Q000627:therapeutic use; D012189:Retrospective Studies
chemical_list: D000935:Antifungal Agents; D009761:Nystatin; D008622:Merbromin